Effect of tDCS Timing on Safety Memory in PTSD
Key facts
- Who runs it
- Butler Hospital
- Where
- Providence, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 62 people enrolled
- Started
- 22 Nov 2019
- Ended
- 31 Jan 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- transcranial direct current stimulation
- Record updated
- 21 October 2025
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Primary diagnosis of PTSD, assessed by the Structured Clinical Interview of DSM-5 (SCID)
- aged 18-70
- ability to speak, read, write, and understand English sufficiently well to complete study procedures and provide informed consent
- Stable psychiatric medication use or treatment for at least 6 weeks
Who cannot take part
- Lifetime history of psychotic or bipolar disorder
- Current moderate or severe substance use disorder; if mild, not under the influence at time of study participation
- current (or past) significant neurological disorder, injury, or other intracranial pathology including severe traumatic brain injury or lifetime history of a) seizure disorder b) primary or secondary CNS tumors c) stroke or d) cerebral aneurysm
- lifetime history of moderate or, current unstable medical conditions
- Any problems that would interfere with study participation, including MRI- or tDCS-related contraindications (e.g., implanted metallic devices/substances, metallic tattoos, pregnancy, claustrophobia, holes in the skull, skin abnormalities under stimulation sites), or indication of colorblindness, or presence of any other condition or circumstance that, in the opinion of the investigator team, has the potential to prevent study completion and/or inability to schedule visit days within the allotted time, and/or to have a confounding effect on outcome assessments
- Acute suicidal or homicidal ideation as detected on screening instruments or in the investigator team's opinion, is likely to attempt suicide within 6 months
Where in United States
- Butler HospitalProvidence, United States
About the trial
What the trial wants to find out
The primary purpose of this study is to investigate the effects of tDCS timing on extinction memory in PTSD. A total of 90 participants will be randomized equally across one of three groups:
Read full original descriptionShow less
1. One group receiving active stimulation during extinction followed by sham stimulation during consolidation 2. One group receiving sham stimulation during extinction followed by active stimulation during consolidation 3. One group receiving sham stimulation both during extinction and consolidation
This study also includes an online sub-study (Aim 2) focused on contextual processing along the PTSD spectrum. The online study tests if there is an association between threat and non-threat learning in contextual and non-contextual situations. A maximum of 500 participants will be recruited using an online, panel-based platform.
The 3 groups in the trial
- Active tDCS during extinction learning followed by sham tDCS during consolidationExisting treatment, for comparison
Active tDCS will be applied during the extinction learning phase followed by sham tDCS during the consolidation phase.
Treatment: transcranial direct current stimulation
- Sham tDCS during extinction learning followed by active tDCS during consolidationExisting treatment, for comparison
Sham tDCS will be applied during the extinction learning phase followed by active tDCS during the consolidation phase.
Treatment: transcranial direct current stimulation
- Sham tDCS during extinction learning followed by sham tDCS during consolidationSham treatment, for comparison
Sham tDCS will be applied during the extinction learning phase followed by sham tDCS during the consolidation phase.
Treatment: transcranial direct current stimulation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 21 October 2025